OUT OF POCKETS SPENDING AMONG BREAST CANCER WOMEN RECEIVING OUT-PATIENT TREATMENT IN A TERTIARY TEACHING HOSPITAL IN KUALA LUMPUR MALAYSIA

  • Jamilah Yusoff Community Health Department, Medical Faculty, University Kebangsaan Malaysia,Jln Yaakob Latif Bandar Tun Razak, 56000 Cheras Kuala Lumpur, Malaysia
  • Aniza Ismail Community Health Department, Medical Faculty, University Kebangsaan Malaysia,Jln Yaakob Latif Bandar Tun Razak, 56000 Cheras Kuala Lumpur, Malaysia
Keywords: out of pocket cost, breast cancer

Abstract

There is lack of information about the estimates of out-of-pocket (OOP) spending among women diagnosed with breast cancer and effects on their family’s financial situation in Malaysia. This study is to determine estimates of out-of-pocket spending among women with breast cancer in HCTM and identify factors that significantly associated with high OOP spending. This cross-sectional study assessed out of pockets spending among breast cancer women in HCTM for breast cancer as out-patient. Sampling unit is a woman who has been diagnosed breast cancer and receiving treatment and follows up in HCTM. A 189 breast cancer women were identified for a 6 months period between July to December 2017. Only those patients who received at least 6 months treatment in HCTM were recruited. Out of pocket spending for treatments for adjuvant therapy and follow up, consultations with other practitioners, care taker fee, equipment and traditional/complementary treatment were collected by face-to-face interview using structured questionnaires. The dependent variable was OOP, analyzed using SSPS v23 for descriptive analysis and both univariate and multivariate analysis.173 out of 186 women were recruited and only 172 were considered for cost calculation (participation rate, 93.0 %) in this study. Total out of pocket spending for breast cancer treatment in 2017 was RM 1,037,446.23 with women’s total means out of pocket spending was RM6031.66 (SD =/- 495.58). The highest percentage of cost component contributed by cost of adjuvant therapy, RM334,056.00 (30.2%) followed by traditional/complementary medicine, RM268,278.00 (24.3%), other expenses/private hospital, RM224,887.00 (20.4%), transportation RM 79,772.52 (7.2%), chemotherapy RM67,300.00 (6.1%), dressing RM54,850.00 (5.0%), equipment/prosthesis RM50,550.00 (4.6%) and care taker cost RM24,661.43 (2.2%). Out of pockets costs from breast cancer in HCTM for 2017 are a burden for women and their family. Financial support provides assistance to the out-of-pocket spending in breast cancer treatment and is able to reduce the financial burden among patients and families.

 

References

Longo, C. J., & Bereza, B. G. (2011a). A Comparative Analysis of Monthly Out-Of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada. Current Oncology, 18(1).

Longo, C. J., & Bereza, B. G. (2011b). Monthly OOP Cost for Breast Cancer Patients Basic Research in Cancer. A Comparative Analysis of Monthly Out-Of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada. Current Oncology, 1–8.

https://www.who.int/health_financing/topics/financial-protection/out-of-pocket-payments/en/

Yin, N.A., Amrizal, M. N.,Aniza, I.,Syed ,M.A.(2020). Determining the Cost and Length of Stay at Intensive Care Units and the Factors Influencing Them in a Teaching Hospital in Malaysia. 21,149-156.

Rajurkar, S. P., Presant, C. A., Bosserman, L. D., & McNatt, W. J. (2011). A Copay Foundation Assistance Support Program for Patients Receiving Intravenous Cancer Therapy. Journal of Oncology Practice, 7(2), 100–102.

Zafar, S. Y., Peppercorn, J. M., Schrag, D., Taylor, D. H., Goetzinger, A. M., Zhong, X., & Abernethy, A. P. (2013). The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out‐of‐Pocket Expenses and the Insured Cancer Patient’s Experience. The Oncologist, 18(4), 381–390.

Aung, Y.N., Nur, A.M., Ismail, A., Aljunid, S.M. (2019). Characteristics and Outcome of High-Cost ICU Patients. Clinicoecon Outcomes Res.,11,505-513.

Gany, F., Ayash, C., Raad, N., Wu, M., Roberts-Eversley, N., Mahmoud, H., Fouad, Y., Fahmy, Y., Asar, H., Salama, A., & El-Shinawi, M. (2020). Financial and food security challenges of Egyptian women undergoing breast cancer treatment. Support Care Cancer. 2020 Dec;28(12):5787-5794.

Ahmadi, F., Farrokh-Eslamlou, H., Yusefzadeh, H., & Alinia, C. (2021). Incidence of household catastrophic and impoverishing health expenditures among patients with Breast Cancer in Iran. BMC Health Services Research, 21(1), 1–9.

Politi M. C., Yen R. W., Elwyn G., O'Malley A. J., Saunders C. H., Schubbe D., Forcino R., Durand M. A. Women Who Are Young, Non-White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed-Effects Regression Analysis. Oncologist. 2021 Jan;26(1):e142-e152

Pisu, M., Azuero, A., Benz, R., McNees, P., & Meneses, K. (2017). Out-of-pocket costs and burden among rural breast cancer survivors. Cancer medicine, 6(3), 572–581.

Ghosh, S. (2011). Catastrophic Payments and Impoverishment due to Out-of-Pocket Health Spending. Economic and Political Weekly, 46(47), 63–70.

Wheeler, S. B., Spencer, J. C., Pinheiro, L. C., Carey, L. A., Olshan, A. F., & Reeder-Hayes, K. E. (2018). Financial Impact of Breast Cancer in Black Versus White Women. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 36(17), 1695–1701.

Callander, E., Bates, N., Lindsay, D., Larkins, S., Topp, S. M., Cunningham, J., Sabesan, S., & Garvey, G. (2019). Long-term out of pocket expenditure of people with cancer: Comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia. International Journal for Equity in Health, 18(1), 1–11.

Farias, A. J., & Du, X. L. (2017). Association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy adherence among medicare patients with breast cancer. Journal of Clinical Oncology, 35(1), 86–95.

Zafar, S. Y. (2016). Financial Toxicity of Cancer Care: It’s Time to Intervene. Journal of the National Cancer Institute, 108(5), 24–27.

Breast Cancer Network Australia. (2017). The financial impact of breast cancer. 1–32.

Lauzier, S., Levesque, P., Mondor, M., Drolet, M., Coyle, D., Brisson, J., Masse, B., Provencher, L., Robidoux, A., & Maunsell, E. (2013). Out-of-pocket costs in the year after early breast cancer among canadian women and spouses. Journal of the National Cancer Institute, 105(4), 280–292.

Meneses, K., Azuero, A., Hassey, L., McNees, P., & Pisu, M. (2012). Does economic burden influence quality of life in breast cancer survivors? Gynecologic Oncology, 124(3), 437–443.

Wharam, J. F., Ross-Degnan, D., & Rosenthal, M. B. (2013). The ACA and High-Deductible Insurance — Strategies for Sharpening a Blunt Instrument. New England Journal of Medicine, 369(16), 1481–1484.

Published
2021-12-28
How to Cite
Yusoff, J., & Ismail, A. (2021). OUT OF POCKETS SPENDING AMONG BREAST CANCER WOMEN RECEIVING OUT-PATIENT TREATMENT IN A TERTIARY TEACHING HOSPITAL IN KUALA LUMPUR MALAYSIA. Malaysian Journal of Public Health Medicine, 21(3), 240-249. https://doi.org/10.37268/mjphm/vol.21/no.3/art.1107